Market Position and Squeeze Risk
Recursion Pharmaceuticals (RXRX) has emerged as the top-ranked ticker on the Tapeboard squeeze monitor, boasting a high squeeze score of 90.2. With 30.8% of its float currently sold short, the stock is exhibiting classic signs of a crowded trade. While the borrow fee remains relatively modest at 0.5%, the high short interest combined with a days-to-cover ratio of 4.9 suggests that any significant positive catalyst could trigger a rapid covering event.
Data Context
It is critical to distinguish between this high open interest and daily flow. The 30.8% figure represents the aggregate open short position, which is significantly more impactful than daily short volume spikes. Investors should monitor the 'Threshold' status, as RXRX is currently flagged, indicating potential persistent failures-to-deliver that often accompany high-conviction short positions.
Signal data sourced from Tapeboard. This post is an original analysis prepared by The Forensic Ledger from publicly available data. Not investment advice.
Not investment advice. This is original reporting and analysis prepared by The Forensic Ledger from publicly available data. Nothing here is a recommendation to buy, sell, or hold any security. Always consult the original source and a licensed professional. See our full disclaimer and source-citation policy.